Publications
Print PDF
Trump's Drug Pricing Plan Pushes for Increased Price Transparency, Greater Use of Generics
May 14, 2018
Paige Minemyer
FierceHealthcare

Axinn partner Chad Landmon was quoted in the FierceHealthcare article, "Trump's Drug Pricing Plan Pushes for Increased Price Transparency, Greater Use of Generics." 

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.